Article | November 15, 2023

Technology Adoption In Clinical Trials: Trends & Plateaus In 2023

Source: OpenClinica

By Ben Baumann

GettyImages-1367732499 digital therapy

Released to the public on November 30, 2022, ChatGPT garnered one million users within a brief five days. By the summer of 2023, ChatGPT expanded its availability to over 30 countries, amassing a user base exceeding 100 million, with approximately 15% being Americans. The company behind ChatGPT, openai.com, recorded an impressive one billion visits to its website per month.

In April 2023, McKinsey & Company conducted its annual survey of global executives, involving 1,684 leaders worldwide. The survey revealed that 79% of these leaders had some exposure to generative AI, either within their professional realm or in personal contexts. The report titled "The State of AI in 2023: Generative AI’s Breakout Year" highlighted that less than a year after the debut of many AI tools, one-third of the respondents reported their organizations regularly using generative AI in at least one business function.

In the realm of healthcare, pharmaceuticals, and medical products companies, 85% of leaders and managers had some exposure to AI. Notably, 23% were using AI regularly, either at work or outside, and 44% had experimented with it at least once.

Delve into the trends and plateaus experienced throughout 2023 regarding technology adoption by accessing the article below.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader